The 10th Vivatech technology show opened in Paris on June 17th, highlighting the growing role of artificial intelligence across industries. This year’s event focuses heavily on AI’s impact, particularly in healthcare and cancer treatment. France is positioned as a leader in this field, with startups driving innovation. Orakl Oncology, a French startup, has developed an AI-powered model designed to identify patients most likely to benefit from specific cancer therapies. This technology aims to improve treatment efficacy by personalizing care based on individual patient profiles. The model represents a unique approach to precision oncology, leveraging AI to enhance patient outcomes. Vivatech serves as a key platform for showcasing these advancements in European technology.